- Home
- MERC vs NTHI Comparison
MERC vs NTHI Comparison
Compare MERC & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MERC
- NTHI
- Stock Information
- Founded
- MERC 1968
- NTHI 2008
- Country
- MERC Canada
- NTHI United States
- Employees
- MERC N/A
- NTHI N/A
- Industry
- MERC Paper
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- MERC Basic Materials
- NTHI Health Care
- Exchange
- MERC Nasdaq
- NTHI Nasdaq
- Market Cap
- MERC 190.9M
- NTHI 195.5M
- IPO Year
- MERC 1987
- NTHI N/A
- Fundamental
- Price
- MERC $1.60
- NTHI $8.15
- Analyst Decision
- MERC Hold
- NTHI
- Analyst Count
- MERC 3
- NTHI 0
- Target Price
- MERC $3.00
- NTHI N/A
- AVG Volume (30 Days)
- MERC 675.0K
- NTHI 59.3K
- Earning Date
- MERC 11-06-2025
- NTHI 11-14-2025
- Dividend Yield
- MERC 13.39%
- NTHI N/A
- EPS Growth
- MERC N/A
- NTHI N/A
- EPS
- MERC N/A
- NTHI N/A
- Revenue
- MERC $1,906,971,000.00
- NTHI $59,990.00
- Revenue This Year
- MERC N/A
- NTHI N/A
- Revenue Next Year
- MERC $13.33
- NTHI N/A
- P/E Ratio
- MERC N/A
- NTHI N/A
- Revenue Growth
- MERC N/A
- NTHI N/A
- 52 Week Low
- MERC $1.55
- NTHI $3.20
- 52 Week High
- MERC $8.28
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- MERC 22.81
- NTHI 39.93
- Support Level
- MERC $1.55
- NTHI $8.93
- Resistance Level
- MERC $1.77
- NTHI $12.00
- Average True Range (ATR)
- MERC 0.16
- NTHI 1.16
- MACD
- MERC -0.02
- NTHI -0.15
- Stochastic Oscillator
- MERC 5.69
- NTHI 7.59
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).